Article Inpatient Labelling 
Pharmacy Joe
FEBRUARY 26, 2025
The study was an open-label, multicenter, randomized controlled trial in 9 Australian Emergency Departments. If you like this post, check outmy book A Pharmacists Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–
Pharmacy Joe
DECEMBER 22, 2021
Subscribe on iTunes , Android , or Stitcher Countless journal articles, podcast episodes, blog posts, and social media posts have been filled up comparing and contrasting the pros and cons of ketamine vs etomidate for sedation prior to rapid sequence intubation (RSI). In this episode, I’ll discuss ketamine vs etomidate for RSI.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Joe
NOVEMBER 24, 2024
Milrinone labeling suggests a renal dose adjustment for patients with creatinine clearance between 10 and 50 mL/min but has no recommendations or data available for patients with ESRD or who are receiving CRRT. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free.
Pharmacy Joe
JANUARY 15, 2025
Such a recommendation, even though it is labeled as weak and based on very low-quality evidence is likely to make its way into hospital protocol in the form of automatically discontinuing a C diff test for a patient with recent laxative use. Members of my Hospital Pharmacy Academy have access to practical trainings on C.
Pharmacy Joe
OCTOBER 22, 2023
In this episode, I’ll discuss an article about cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection. This trial is not without weakness given that it was open-label, 20% of patients received at least 1 dose of the unassigned antibiotic, and the mean duration of therapy was short at only three days.
Pharmacy Joe
OCTOBER 22, 2023
In this episode, I’ll discuss an article about cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection. This trial is not without weakness given that it was open-label, 20% of patients received at least 1 dose of the unassigned antibiotic, and the mean duration of therapy was short at only three days.
Pharmacy Joe
SEPTEMBER 7, 2022
Milrinone labeling suggests a renal dose adjustment for patients with creatinine clearance between 10 and 50 mL/min but has no recommendations or data available for patients with ESRD or who are receiving CRRT.
Expert insights. Personalized for you.
52 
Let's personalize your content